GeneQuantum Healthcare, a Chinese high-tech company focused on the research and development of innovative bio-therapeutics, announced on Wednesday that it has raised nearly RMB100 million (US$14.76 million) in a pre-B round of financing led by private equity firm Huagai Capital.

UNLOCK DATASubscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech